Research progress of multimodal cardiac magnetic resonance in evaluating cardiac function and tissue characteristics of perpartum cardiomyopathy
-
摘要: 围生期心肌病是发生于妊娠终末期或产后数个月的特发性心肌病变，临床表现为无明显诱因的左心室收缩功能障碍引起的心力衰竭。围生期心肌病起病急，是引起产妇死亡的重要原因，早期诊断和及时治疗极其重要。多模态心脏磁共振可以无创、准确、多方位评价心脏的结构、功能和心肌的组织特征。本文就心脏磁共振在围生期心肌病中应用进展进行综述。Abstract: Peripartum cardiomyopathy(PPCM) is an idiopathic cardiomyopathy that occurs at the end of pregnancy or a few months after delivery. The clinical manifestation is heart failure caused by left ventricular systolic dysfunction with no obvious cause. PPCM usually has an acute onset and might rapidly progress to end-stage heart failure. Therefore, early diagnosis and timely treatment are vital to clinical practice. Cardiac magnetic resonance was used because of the non-invasive and accurate evaluation of heart function, structure, and tissue characterization. This review summarizes the clinical application and future development of cardiac magnetic resonance in peripartum cardiomyopathy.
-
Key words:
- cardiomyopathy /
- peripartum /
- cardiac magnetic resonance
-
-
[1] Davis MB, Arany Z, McNamara DM, et al. Peripartum cardiomyopathy: JACC State-of-the-art review[J]. J Am Coll Cardiol, 2020, 75(2): 207-221.
[2] Arany Z, Elkayam U. Peripartum cardiomyopathy[J]. Circulation, 2016, 133(14): 1397-1409. doi: 10.1161/CIRCULATIONAHA.115.020491
[3] Honigberg MC, Givertz MM. Peripartum cardiomyopathy[J]. BMJ, 2019, 364: k5287.
[4] Bauersachs J, König T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy[J]. Eur J Heart Fail, 2019, 21(7): 827-843. doi: 10.1002/ejhf.1493
[5] 郭潇潇, 刘永太, 方理刚, 等. 围产期心肌病的临床特点及预后分析[J]. 中华内科杂志, 2016, 55(2): 127-130. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG202101011.htm
[6] Fidziańska A, Walczak E, Glinka Z, et al. Ultrastructural evidence of myocardial capillary remodeling in peripartum cardiomyopathy[J]. Med Sci Monit, 2010, 16(5): CS62-CS66.
[7] Barone-Rochette G, Rodière M, Lantuejoul S. Value of cardiac MRI in peripartum cardiomyopathy[J]. Arch Cardiovasc Dis, 2011, 104(4): 263-264. doi: 10.1016/j.acvd.2010.07.006
[8] Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy[J]. Eur J Heart Fail, 2018, 20(6): 951-962. doi: 10.1002/ejhf.1178
[9] McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: Results of the IPAC Study(Investigations of Pregnancy-Associated Cardiomyopathy)[J]. J Am Coll Cardiol, 2015, 66(8): 905-914. doi: 10.1016/j.jacc.2015.06.1309
[10] 巫雪飞, 张妍, 张骞, 等. 围产期心肌病患者左心室逆重构的发生率及预测因素分析[J]. 中华心力衰竭和心肌病杂志(中英文), 2019, 3(2): 100-105.
[11] Haghikia A, Röntgen P, Vogel-Claussen J, et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study[J]. ESC Heart Fail, 2015, 2(4): 139-149. doi: 10.1002/ehf2.12059
[12] Peters A, Caroline M, Zhao H, et al. Initial right ventricular dysfunction severity identifies severe peripartum cardiomyopathy phenotype with worse early and overall outcomes: A 24-year cohort study[J]. J Am Heart Assoc, 2018, 7(9).
[13] Briasoulis A, Mocanu M, Marinescu K, et al. Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy[J]. Echocardiography, 2016, 33(9): 1354-1360. doi: 10.1111/echo.13277
[14] Sugahara M, Kagiyama N, Hasselberg NE, et al. Global left ventricular sStrain at presentation is associated with subsequent recovery in patients with peripartum cardiomyopathy[J]. J Am Soc Echocardiogr, 2019, 32(12): 1565-1573. doi: 10.1016/j.echo.2019.07.018
[15] Arora NP, Mohamad T, Mahajan N, et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy[J]. Am J Med Sci, 2014, 347(2): 112-117. doi: 10.1097/MAJ.0b013e31828155e3
[16] Renz DM, Röttgen R, Habedank D, et al. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging[J]. Rofo, 2011, 183(9): 834-841. doi: 10.1055/s-0031-1281600
[17] Liang YD, Xu YW, Li WH, et al. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping[J]. J Cardiovasc Magn Reson, 2020, 22(1): 2. doi: 10.1186/s12968-019-0590-z
[18] Kawano H, Tsuneto A, Koide Y, et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy[J]. Intern Med, 2008, 47(2): 97-102. doi: 10.2169/internalmedicine.47.0316
[19] 袁思殊, 李志伟, 马晓玲, 等. MR诊断围产期心肌病一例[J]. 放射学实践, 2013, 28(11): 1186. https://www.cnki.com.cn/Article/CJFDTOTAL-FSXS201311039.htm
[20] Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging[J]. Eur Radiol, 2008, 18(12): 2765-2769.
[21] Schelbert EB, Elkayam U, Cooper LT, et al. Myocardial Damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy[J]. J Am Heart Assoc, 2017, 6(4).
[22] Ersbøll AS, Bojer AS, Hauge MG, et al. Long-Term cardiac function after peripartum cardiomyopathy and preeclampsia: A danish nationwide, clinical follow-up study using maximal exercise testing and cardiac magnetic resonance imaging[J]. J Am Heart Assoc, 2018, 7(20): e008991.
[23] Arora NP, Mohamad T, Mahajan N, et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy[J]. Am J Med Sci, 2014, 347(2): 112-117.
[24] Nakamori S, Dohi K, Ishida M, et al. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy[J]. JACC Cardiovasc Imaging, 2018, 11(1): 48-59.
[25] 崔越, 曹玉坤, 刘佳, 等. 心脏磁共振T1 mapping和特征追踪技术定量评价肥厚型心肌病患者心肌纤维化和形变[J]. 临床心血管病杂志, 2020, 36(9): 856-862. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202009017.htm
[26] Nii M, Ishida M, Dohi K, et al. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique[J]. J Cardiovasc Magn Reson, 2018, 20(1): 52.
[27] Sliwa K, Mebazaa A, Hilfiker-Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy(PPCM): EUR Observational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM[J]. Eur J Heart Fail, 2017, 19(9): 1131-1141.
[28] Ricci F, De Innocentiis C, Verrengia E, et al. The role of multimodality cardiovascular imaging in peripartum cardiomyopathy[J]. Front Cardiovasc Med, 2020, 7: 4.
[29] Liu X, Yang ZG, Gao Y, et al. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study[J]. Cardiovasc Diabetol, 2018, 17(1): 139.
[30] Yin L, Xu HY, Zheng SS, et al. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy[J]. Int J Cardiovasc Imaging, 2017, 33(12): 1949-1959.
[31] Xue H, Brown L, Nielles-Vallespin S, et al. Automatic in-line quantitative myocardial perfusion mapping: Processing algorithm and implementation[J]. Magn Reson Med, 2020, 83(2): 712-730.
[32] Asad Z, Maiwand M, Farah F, et al. Peripartum cardiomyopathy: A systematic review of the literature[J]. Clin Cardiol, 2018, 41(5): 693-697.
-
计量
- 文章访问数: 989
- PDF下载数: 378
- 施引文献: 0
下载: